4.5 Article

Analysis of recent shared ancestry in a familial cohort identifies coding and noncoding autism spectrum disorder variants

Journal

NPJ GENOMIC MEDICINE
Volume 7, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41525-022-00284-2

Keywords

-

Funding

  1. University of Texas Southwestern Medical Center
  2. Walter and Lillian Cantor Foundation
  3. University of Toronto McLaughlin Centre
  4. Centre for Applied Genomics
  5. Autism Speaks
  6. Autism Speaks Canada
  7. University of Toronto
  8. Hospital for Sick Children
  9. SickKids Foundation

Ask authors/readers for more resources

This study conducted whole genome sequencing on individuals with autism spectrum disorder (ASD) and identified potentially causative variants in known and candidate ASD genes. By combining homozygosity mapping and regulatory element annotations, they emphasized the importance of leveraging recent shared ancestry to map disease variants in complex neurodevelopmental disorders.
Autism spectrum disorder (ASD) is a collection of neurodevelopmental disorders characterized by deficits in social communication and restricted, repetitive patterns of behavior or interests. ASD is highly heritable, but genetically and phenotypically heterogeneous, reducing the power to identify causative genes. We performed whole genome sequencing (WGS) in an ASD cohort of 68 individuals from 22 families enriched for recent shared ancestry. We identified an average of 3.07 million variants per genome, of which an average of 112,512 were rare. We mapped runs of homozygosity (ROHs) in affected individuals and found an average genomic homozygosity of 9.65%, consistent with expectations for multiple generations of consanguineous unions. We identified potentially pathogenic rare exonic or splice site variants in 12 known (including KMT2C, SCN1A, SPTBN1, SYNE1, ZNF292) and 12 candidate (including CHD5, GRB10, PPP1R13B) ASD genes. Furthermore, we annotated noncoding variants in ROHs with brain-specific regulatory elements and identified putative disease-causing variants within brain-specific promoters and enhancers for 5 known ASD and neurodevelopmental disease genes (ACTG1, AUTS2, CTNND2, CNTNAP4, SPTBN4). We also identified copy number variants in two known ASD and neurodevelopmental disease loci in two affected individuals. In total we identified potentially etiological variants in known ASD or neurodevelopmental disease genes for similar to 61% (14/23) of affected individuals. We combined WGS with homozygosity mapping and regulatory element annotations to identify candidate ASD variants. Our analyses add to the growing number of ASD genes and variants and emphasize the importance of leveraging recent shared ancestry to map disease variants in complex neurodevelopmental disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available